Skip to main content

Editas Medicine, Inc.

EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001650664

In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Editas Medicine, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026All holders in Q4 2025

13F holders of EDIT: Q4 2025 compared with Q1 2026
MeasureQ4 2025Of which not filed for Q1 2026Q1 2026Change
Holders1973208+14
Shares49.9M8.22M51.8M+10.1M (+24.2%)
Value$102.5M$16.8M$127.5M+$41.9M (+48.9%)

3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (38)

Institutions that held Editas Medicine, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to EDIT in Q1 2026
InstitutionSharesValue% of portfolio
Vanguard Capital Management LLC4,204,369$10.4M0.00%
Vanguard Portfolio Management LLC3,148,570$7.78M0.00%
Opaleye Management Inc.1,926,997$4.76M0.63%
Mackenzie Financial Corp730,054$1.80M0.00%
Vanguard Fiduciary Trust Co614,036$1.52M0.00%
Marshall Wace, LLP210,308$519.5K0.00%
Prudential Financial Inc66,360$163.9K0.00%
Cerity Partners LLC45,080$111.3K0.00%
Winton Group Ltd43,800$108.2K0.00%
Vanguard Global Advisers, LLC42,863$105.9K0.00%
Mercer Global Advisors Inc25,782$63.7K0.00%
Creative Planning23,084$57.0K0.00%
Group One Trading, L.P.22,309$55.1K0.00%
State of Wyoming17,380$42.9K0.01%
Pallas Capital Advisors LLC16,576$40.9K0.00%
Buckingham Strategic Partners14,806$36.6K0.00%
Abel Hall, LLC14,443$35.7K0.01%
HRT Financial LP14,515$35.0K0.00%
Dynamic Technology Lab Private Ltd14,044$34.7K0.01%
Equitable Holdings, Inc.15,509$31.8K0.00%
Integrated Wealth Concepts LLC12,277$30.3K0.00%
CIBC Bancorp USA Inc.12,255$30.3K0.00%
Headlands Technologies LLC11,853$29.3K0.00%
Merit Financial Group, LLC11,576$28.6K0.00%
Valeo Financial Advisors, LLC10,042$24.8K0.00%
Owl Creek Wealth Partners LLC2,385$5.89K0.00%
Forum Finance Group S.A.2,500$5.00K0.00%
Costello Asset Management, INC1,000$2.47K0.00%
Caitong International Asset Management Co., Ltd642$1.59K0.00%
Root Financial Partners, LLC503$1.24K0.00%
UBS Asset Management Americas Inc480$1.19K0.00%
Gill Capital Partners, LLC425$1.05K0.00%
Innovative Asset Advisors Group, LLC200$4940.00%
Vanguard National Trust Co156$3850.00%
Harbour Investments, Inc.121$3000.00%
Advisory Services Network, LLC65$1610.00%
SJS Investment Consulting Inc.42$1040.00%
Quantbot Technologies LP17$420.00%

Sold out (24)

Institutions that held Editas Medicine, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Not filed for Q1 2026 yet (3)

Institutions that held Editas Medicine, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding EDIT in Q4 2025 that haven't filed for Q1 2026
InstitutionShares, Q4 2025Value, Q4 2025
Vanguard Group Inc8,208,068$16.8M
CIBC Private Wealth Group, LLC7,300$15.0K
Comerica Bank54$111